Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The cyclosporine A-induced decrease in rat renal calbindin-D28kDa protein as a consequence of a decrease in its mRNA

O Grenet1, M C Varela, F Staedtler

  • 1Preclinical Safety, Novartis Pharma AG, Basel, Switzerland.

Biochemical Pharmacology
|May 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diel rhythm of volatile emissions of males and females of the peach fruit fly Bactrocera zonata.

Journal of insect physiology·2019
Same author

[Sleep Apnea and Mechanical Ventilation - Impact on Clinical Course and Perioperative Management].

Pneumologie (Stuttgart, Germany)·2017
Same author

Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease.

Alimentary pharmacology & therapeutics·2016
Same author

Mechanism and Kinetics of Acetyl-Lysine Binding to Bromodomains.

Journal of chemical theory and computation·2015
Same author

Cardiac findings in obesity hypoventilation syndrome: is there a need for specific approach and evaluation?

Internal medicine journal·2015
Same author

Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replication.

Nature·2015
Same journal

Notch signaling in anti-VEGF resistant arteriolar choroidal neovascularization.

Biochemical pharmacology·2026
Same journal

Methylated SNHG3 lncRNA counteracts PSMD4-inhibited angiogenesis by HnRNPA2B1 SUMOylation in peripheral arterial disease.

Biochemical pharmacology·2026
Same journal

The organelle-targeting duality of nanomaterials: physicochemical property-guided therapeutic effects and toxicological outcomes.

Biochemical pharmacology·2026
Same journal

The central role of endoplasmic reticulum stress in Parkinson's disease and targeted therapeutic strategies.

Biochemical pharmacology·2026
Same journal

Mechanisms involved in the regulation of carbohydrate and lipid metabolism by oleanane-type pentacyclic triterpenes.

Biochemical pharmacology·2026
Same journal

Myricitrin alleviates paraquat-induced acute lung injury via PERK pathway to attenuate endoplasmic reticulum stress and mitochondrial dysfunction.

Biochemical pharmacology·2026
See all related articles

Cyclosporine A (CsA) reduces kidney calbindin-D28kDa protein by decreasing its mRNA levels. This finding explains a key mechanism behind CsA's adverse renal effects in rats.

Area of Science:

  • Nephrology
  • Pharmacology
  • Molecular Biology

Background:

  • Cyclosporine A (CsA) is a vital immunosuppressant.
  • CsA treatment can cause significant renal side-effects.
  • Previous studies linked CsA to reduced kidney calbindin-D28kDa protein levels.

Purpose of the Study:

  • Investigate the molecular mechanisms behind CsA-induced calbindin-D28kDa down-regulation in rat kidneys.
  • Determine if CsA affects calbindin-D28kDa at the mRNA or protein level.
  • Elucidate the relationship between CsA dosage and calbindin-D28kDa expression.

Main Methods:

  • Male Wistar rats were administered CsA at 15 or 50 mg/kg/day for 12 days.
  • Kidney tissue was analyzed for calbindin-D28kDa mRNA levels using reverse transcription followed by polymerase chain reaction (RT-PCR).

Related Experiment Videos

  • Calbindin-D28kDa protein abundance was also measured.

    • Main Results:

    • A marked, dose-dependent decrease in calbindin-D28kDa mRNA was observed in CsA-treated rats.
    • The reduction in mRNA levels closely mirrored the observed decrease in calbindin-D28kDa protein abundance.
    • Both tested doses of CsA significantly impacted calbindin-D28kDa expression.

    Conclusions:

    • CsA-induced down-regulation of renal calbindin-D28kDa protein is primarily mediated by a decrease in its corresponding mRNA levels.
    • This molecular mechanism contributes to the adverse renal effects associated with Cyclosporine A therapy.
    • Understanding this pathway may inform strategies to mitigate CsA nephrotoxicity.